Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Juntendo University
We attempted to reduce the dose of antipsychotics to ≤1000-mg chlorpromazine eq./day. The dose was gradually reduced at a rate of ≤50-mg chlorpromazine eq./week, and the reduction was discontinued if the subjects relapsed. The differences in baseline cognitive function were analyzed between the patients with no relapse and relapse groups.
Age
20–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
inpatients with a diagnosis of schizophrenia, and
those in the chronic phase receiving mean daily antipsychotic doses exceeding 1000-mg chlorpromazine eq./day.
You may not be if
mental retardation,
substance abuse or dependence,
a history of major head trauma,
serious medical or neurological disorders, or
depot antipsychotic injections within the previous 3 months and electroconvulsive therapy within the previous 6 months
Clareo Health | Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction
